XOMA
XOMA Corp
NASDAQ: XOMA · HEALTHCARE · BIOTECHNOLOGY
$40.94
-0.12% today
Updated 2026-04-30
Market cap
$497.18M
P/E ratio
28.08
P/S ratio
9.53x
EPS (TTM)
$1.46
Dividend yield
—
52W range
$22 – $43
Volume
0.2M
XOMA Corp (XOMA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
60.80%
Operating margin
15.90%
ROE
34.10%
ROA
2.88%
Debt/equity
1.22x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $29.50M | $-51.84M | 100.00% | -137.92% | -175.74% |
| 2007 | $84.25M | $-12.33M | 100.00% | -3.02% | -14.63% |
| 2008 | $67.99M | $-45.24M | 100.00% | -56.97% | -66.55% |
| 2009 | $98.43M | $550000.00 | 100.00% | 13.17% | 0.56% |
| 2010 | $33.64M | $-68.76M | 100.00% | -199.47% | -204.38% |
| 2011 | $58.20M | $-32.74M | 100.00% | -58.35% | -56.26% |
| 2012 | $33.78M | $-71.06M | 99.58% | -167.62% | -210.36% |
| 2013 | $35.45M | $-124.06M | 22.82% | -164.18% | -349.94% |
| 2014 | $18.87M | $-38.30M | -56.19% | -433.75% | -203.02% |
| 2015 | $55.45M | $-20.61M | 62.67% | -71.64% | -37.16% |
| 2016 | $5.56M | $-53.53M | 74.84% | -1,106.36% | -962.08% |
| 2017 | $52.69M | $14.60M | 85.05% | 32.32% | 27.70% |
| 2018 | $5.30M | $-13.34M | 68.26% | -318.12% | -251.80% |
| 2019 | $18.37M | $-1.98M | 93.18% | -21.15% | -10.79% |
| 2020 | $29.39M | $13.30M | 99.42% | 42.25% | 45.25% |
| 2021 | $38.16M | $15.80M | 99.55% | 45.94% | 41.40% |
| 2022 | $6.03M | $-17.10M | 95.45% | -288.93% | -283.79% |
| 2023 | $4.76M | $-40.83M | 96.99% | -879.53% | -858.15% |
| 2024 | $28.49M | $-13.82M | 99.28% | -140.33% | -48.52% |
| 2025 | $52.15M | $31.71M | 94.32% | 21.83% | 60.81% |